Transmucosal delivery of GDNF is equivalent to direct intrastriatal injection at ameliorating the behavioral and immunohistological features of Parkinson disease in a murine model. Mucosal grafting of arachnoid defects is a technique commonly used for endoscopic skull base reconstruction and may represent a novel method to permanently bypass the blood-brain barrier.
You Might Also Like:
- Tinnitus Research Implicates Brain Structures in Hearing Disorder
- Nose News: Sleep-Disordered Breathing, Middle Meatal Stents
- Does Total Intravenous Anesthesia Provide Significant Blood Loss Reduction During ESS?
- Should More Conservative Blood Transfusion Thresholds Be Adopted in Head and Neck Surgery?